536565-BOM

Novelix Pharmaceuticals Ltd.

Industry Group: Retailing
Industry: Pharmacy Retail
70.64-1.4 (-1.89%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Novelix Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Novelix Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • EGM2 Jul 2026
    Shareholders Meeting - EGM- Voting Results
    Submission of Voting results.
  • EGM2 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Submission of Voting Results along with Scrutinizers report.
  • EGM1 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of EGM
    Submission of outcome of Extra Ordinary General Meeting.
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Submission of trading window closure intimation.
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A22 Jun 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Newspaper Publication19 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submission of newspaper publication of corrigendum to the EGM Notice.
  • EGM17 Jun 2026
    Shareholders Meeting- Corrigendum To The EGM Notice Of The EGM Scheduled To Be Held On 01St July, 2026.
    Submission of Corrigendum to the EGM Notice dated 04th June, 2026 of the EGM to be held on 01st July, 2026.
  • Newspaper Publication15 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication for intimation of special window.
  • Newspaper Publication10 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication EGM Notice.
  • EGM9 Jun 2026
    Shareholders Meeting- Notice Of Extra-Ordinary General Meeting Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Notice of Extra Ordinary General Meeting
  • Preferential Issue5 Jun 2026
    Announcement under Regulation 30 (LODR)-Preferential Issue
    Submission of Intimation of Preferential Issue.
  • EGM5 Jun 2026
    Shareholders Meeting - EGM On 01St July, 2026.
    Submission of intimation of EGM, Cut-off Date and Remote e-voting period.
  • Outcome of Board Meeting4 Jun 2026
    Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations, 2015
    Outcome of the Board meeting held on today 04th June, 2026.
  • General3 Jun 2026
    Announcement Under Regulation 30 (LODR) - Intimation Regarding The Execution Of An Agreement With GMBU
    Intimation of production scale up agreement.
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20113 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gattu Gnana Prakash & Others
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20113 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vrupparapalli Reddy & Vrupparapalli Pavani
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20113 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srinidhi Fine- Chemicals Llp & Other
  • Code of Conduct under SEBI (PIT) Regulations, 20152 Jun 2026
    Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
    Submission of Intimation of Allotment of equity shares to promoters and promoter group.
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20112 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srindhi Fine Chemicals LLP
  • Board Meeting1 Jun 2026
    Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Thursday, 04Th June, 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2026 ,inter alia, to consider and approve 1. To consider and ....

Frequently Asked Questions

Where can I download the annual report of Novelix Pharmaceuticals Ltd.?
Annual reports of Novelix Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Novelix Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Novelix Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Novelix Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Novelix Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Novelix Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Novelix Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Novelix Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Novelix Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Novelix Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Novelix Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Novelix Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Novelix Pharmaceuticals Ltd. is INE314I01036. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Novelix Pharmaceuticals Ltd. listed?
Novelix Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 536565-BOM and the BSE code is -.
Where can I find the shareholding pattern of Novelix Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Novelix Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Novelix Pharmaceuticals Ltd. on Sharpely?
Share price data for Novelix Pharmaceuticals Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.